Split History
ETFs Holding CXM »    CXM Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cardium Therapeutics is a medical technology company focused on the development and commercialization of a portfolio of products and devices. Co.'s Cardium Biologics business is developing Generx® for the treatment of myocardial ischemia due to coronary artery disease. Co.'s Tissue Repair Company subsidiary is developing and commercializing Excellagen® fibrillar collagen-based topical gel for the management of diabetic foot ulcers and other dermal wounds. Co.'s MedPodium Health Sciences, Inc. subsidiary includes its To Go Brands, Inc. subsidiary business, which is engaged in developing and marketing a line of nutraceuticals and other products. According to our CXM split history records, CXM has had 1 split.
CXM split history picture
CXM (CXM) has 1 split in our CXM split history database. The split for CXM took place on July 18, 2013. This was a 1 for 20 reverse split, meaning for each 20 shares of CXM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as CXM conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the CXM split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CXM shares, starting with a $10,000 purchase of CXM, presented on a split-history-adjusted basis factoring in the complete CXM split history. CXM split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/25/2010
End date: 01/23/2014
Start price/share: $9.40
End price/share: $0.76
Dividends collected/share: $0.00
Total return: -91.91%
Average Annual Total Return: -49.62%
Starting investment: $10,000.00
Ending investment: $808.60
Years: 3.67
Date Ratio
07/18/20131 for 20
CXM is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CYCC Split History
CYH Split History
CYTK Split History
CYTR Split History
CYTX Split History
DARA Split History
DCTH Split History
DFFN Split History
DGX Split History
DHR Split History

Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
Cyclacel Pharmaceuticals, Inc. (CYCC)
Chesapeake Energy Corporation (CHK)
Direxion Daily Gold Miners Index Bull 3X Shares (NUGT)
Direxion Zacks MLP High Income Index Shares (ZMLP)
Direxion Daily Retail Bull 3X Shares (RETL)
Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 3X Shares (UBOT)
Direxion Daily Junior Gold Miners Index Bull 3X Shares (JNUG)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CXM Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.